Previous Webinar

Georg Winter is Principal Investigator at CeMM as well as co-founder of the biotech companies Proxygen and Solgate. In his lab at CeMM he is focusing on targeted protein degradation and especially on molecular glue degraders as these molecules cause the complete elimination of harmful proteins and constitute a new avenue towards targeting proteins that were previously considered “undruggable”. His lab connects basic research in gene regulation and the ubiquitin-proteasome system with functional genomics and chemical probe development to develop novel and personalized therapeutic paradigms.

Danette Daniels is Vice President of the Protein Degrader Platform at Foghorn Therapeutics which she joined recently. She was an early leader in the field of targeted protein degradation, pioneering approaches to monitor cellular kinetics of degradation and most recently, co-developing a new PROTAC modality. Prior to joining Foghorn Therapeutic Danette has been R&D Group Leader of Functional Proteomics at Promega Corporation.